Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Net Cash Flow (2021 - 2026)

Alvotech's (ALVO) quarterly Net Cash Flow came in at $78.8 million in Q2 2026, down 28.53% on a YoY basis from $110.3 million in Q2 2025, and up 173.26% quarter-over-quarter from -$107.6 million in Q1 2026.

Analysis

Alvotech (ALVO) Net Cash Flow (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Net Cash Flow for 6 consecutive years, with $78.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow fell 28.53% year-over-year to $78.8 million; the trailing twelve-month figure through Jun 2026 stood at -$9.0 million (up 81.3% YoY), and the FY2025 full-year result was $116.4 million, up 179.89% from the prior year.
  • Net Cash Flow improved to $78.8 million in Q2 2026 per ALVO's latest filing, from -$107.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $338.4 million in Q4 2025 and bottomed at -$375.9 million in Q4 2022.
  • Historically, Net Cash Flow has averaged -$66.4 million across 5 years, with a median of -$54.8 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Net Cash Flow jumped 305.44% in 2025, then plunged 686.2% in 2026.
  • Over 5 years, Net Cash Flow stood at -$375.9 million in 2022, then gained by 10.12% to -$337.9 million in 2023, then gained by 25.59% to -$251.4 million in 2024, then soared by 234.62% to $338.4 million in 2025, then sank by 76.71% to $78.8 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $78.8 million, -$107.6 million, and $338.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -81.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -912.40 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -44.45 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -64.63 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 528.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 78.82 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 48.97 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 52.66 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.82 Mn
Mar 31, 2026 -107.59 Mn
Dec 31, 2025 338.45 Mn
Sep 30, 2025 -318.63 Mn
Jun 30, 2025 110.29 Mn
Mar 31, 2025 -13.69 Mn
Dec 31, 2024 -251.42 Mn
Sep 30, 2024 106.94 Mn
Jun 30, 2024 -53.68 Mn
Mar 31, 2024 54.30 Mn
Dec 31, 2023 -337.86 Mn
Jun 30, 2023 -55.95 Mn
Dec 31, 2022 -375.93 Mn
Jun 30, 2022 -103.57 Mn
Dec 31, 2021 -70.76 Mn
Sep 30, 2021 -72.68 Mn